Single-dose rATG induction at renal transplantation: Superior renal function and glucoregulation with less hypomagnesemia

Clinical Transplantation

Volumn 26, Issue 1, 2012, Pages 123-132

  Stevens, R Brian ^a   Lane, James T ^a   Boerner, Brian P ^a   Miles, Clifford D ^a   Rigley, Theodore H ^a   Sandoz, John P ^b   Nielsen, Kathleen J ^a   Skorupa, Jill Y ^a   Skorupa, Anna J ^a   Kaplan, Bruce ^c   Wrenshall, Lucile E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Sigma Analytics   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Hyperglycemia; Hypomagnesemia; Kidney transplantation; Magnesium; New onset diabetes after transplantation; Rabbit anti thymocyte globulin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; MAGNESIUM ION; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOMAGNESEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; SINGLE DRUG DOSE;

ADULT; AGED; ANIMALS; ANTILYMPHOCYTE SERUM; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RABBITS; RENAL TUBULAR TRANSPORT, INBORN ERRORS; SURVIVAL RATE; YOUNG ADULT;

EID: 79960983881     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01425.x     Document Type: Article

References (40)

1. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003: 3: 178.
2. Sulanc E, Lane JT, Puumala SE, Groggel GC, Wrenshall LE, Stevens RB. New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. Transplantation 2005: 80: 945.
3. Rodrigo E, Fernandez-Fresnedo G, Valero R et al. New-onset diabetes after kidney transplantation: risk factors. J Am Soc Nephrol 2006: 17: S291.
4. Johnston O, Rose CL, Webster AC, Gill JS. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008: 19: 1411.
5. Jackson CE, Meier DW. Routine serum magnesium analysis. Correlation with clinical state in 5, 100 patients. Ann Intern Med 1968: 69: 743.
6. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993: 21: 1024.
7. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003: 26: 1147.
8. Vincenti F, Friman S, Scheuermann E et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007: 7: 1506.
9. Pham PC, Pham PM, Pham PT, Pham SV, Pham PA, Pham PT. The link between lower serum magnesium and kidney function in patients with diabetes mellitus type 2 deserves a closer look. Clin Nephrol 2009: 71: 375.
10. Van Laecke S, Van Biesen W, Verbeke F, De Bacquer D, Peeters P, Vanholder R. Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of new-onset diabetes after transplantation. Am J Transplant 2009: 9: 2140.
11. Beiras-Fernandez A, Chappell D, Hammer C, Beiras A, Reichart B, Thein E. Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury. Transpl Immunol 2009: 20: 224.
12. Stevens RB, Mercer DF, Grant WJ et al. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. Transplantation 2008: 85: 1391.
13. Mehrabi A, Mood Zh A, Sadeghi M et al. Thymoglobulin and ischemia reperfusion injury in kidney and liver transplantation. Nephrol Dial Transplant 2007: 22(Suppl 8): viii54.
14. Kyllonen LE, Eklund BH, Pesonen EJ, Salmela KT. Single bolus antithymocyte globulin versus basiliximab induction in kidney transplantation with cyclosporine triple immunosuppression: efficacy and safety. Transplantation 2007: 84: 75.
15. LaCorcia G, Swistak M, Lawendowski C et al. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion. Transplantation 2009: 87: 966.
16. Chakkera HA, Weil EJ, Castro J et al. Hyperglycemia during the immediate period after kidney transplantation. Clin J Am Soc Nephrol 2009: 4: 853.
17. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003: 75: SS3.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999: 130: 461.
19. Bouma HR, Ploeg RJ, Schuurs TA. Signal transduction pathways involved in brain death-induced renal injury. Am J Transplant 2009: 9: 989.
20. Mueller TF, Einecke G, Reeve J et al. Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant 2007: 7: 2712.
21. Mueller TF, Reeve J, Jhangri GS et al. The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant 2008: 8: 78.
22. Flechner SM, Kurian SM, Head SR et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004: 4: 1475.
23. Beiras-Fernandez A, Chappell D, Hammer C, Thein E. Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model. Transpl Immunol 2006: 15: 273.
24. Goggins WC, Pascual MA, Powelson JA et al. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003: 76: 798.
25. Bunnag S, Einecke G, Reeve J et al. Molecular correlates of renal function in kidney transplant biopsies. J Am Soc Nephrol 2009: 20: 1149.
26. Mengel M, Reeve J, Bunnag S et al. Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts. Am J Transplant 2009: 9: 169.
27. Ghisdal L, Baron C, Le Meur Y et al. TCF7L2 polymorphism associates with new-onset diabetes after transplantation. J Am Soc Nephrol 2009: 20: 2459.
28. Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 2008: 31: 289.
29. Larsen CM, Faulenbach M, Vaag A et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007: 356: 1517.
30. Nijenhuis T, Hoenderop JG, Bindels RJ. Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol 2004: 15: 549.
31. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002: 25: 583.
32. Van Hooff JP, Christiaans MH, Van Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005: 79: 1465.
33. Larsen JL, Bennett RG, Burkman T et al. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. Transplantation 2006: 82: 466.
34. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol 2006: 6: 633.
35. Stevens RB, Wang YL, Kaji H et al. Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. Transplant Proc 1993: 25: 382.
36. Wrenshall LE, Stevens RB, Cerra FB, Platt JL. Modulation of macrophage and B cell function by glycosaminoglycans. J Leukoc Biol 1999: 66: 391.
37. Wrenshall LE, Platt JL. Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J Immunol 1999: 163: 3793.
38. Wrenshall LE, Cerra FB, Singh RK, Platt JL. Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes. J Immunol 1995: 154: 871.
39. Pulskens WP, Teske GJ, Butter LM et al. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 2008: 3: e3596.
40. Downie GH, Ryan US, Hayes BA, Friedman M. Interleukin-2 directly increases albumin permeability of bovine and human vascular endothelium in vitro. Am J Respir Cell Mol Biol 1992: 7: 58.